Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioRestorative Therapies (BRTX) Amortization - Intangibles (2016 - 2021)

Historic Amortization - Intangibles for BioRestorative Therapies (BRTX) over the last 11 years, with Q1 2021 value amounting to $417160.0.

  • BioRestorative Therapies' Amortization - Intangibles fell 6088.61% to $417160.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $4.0 million, marking a year-over-year decrease of 760.14%. This contributed to the annual value of $2.3 million for FY2018, which is 26972.66% up from last year.
  • According to the latest figures from Q1 2021, BioRestorative Therapies' Amortization - Intangibles is $417160.0, which was down 6088.61% from $1.1 million recorded in Q1 2020.
  • In the past 5 years, BioRestorative Therapies' Amortization - Intangibles ranged from a high of $1.5 million in Q3 2019 and a low of $84167.0 during Q2 2017
  • In the last 5 years, BioRestorative Therapies' Amortization - Intangibles had a median value of $417160.0 in 2021 and averaged $585726.7.
  • In the last 5 years, BioRestorative Therapies' Amortization - Intangibles surged by 118551.81% in 2018 and then crashed by 6088.61% in 2021.
  • Over the past 5 years, BioRestorative Therapies' Amortization - Intangibles (Quarter) stood at $242380.0 in 2017, then surged by 67.29% to $405475.0 in 2018, then soared by 266.85% to $1.5 million in 2019, then fell by 28.3% to $1.1 million in 2020, then crashed by 60.89% to $417160.0 in 2021.
  • Its Amortization - Intangibles was $417160.0 in Q1 2021, compared to $1.1 million in Q1 2020 and $1.5 million in Q3 2019.